ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,299Medicare Part D Prescriptions Filled, Including Refills

Rank: 9 out of 300

$697K Total Retail Price of All Prescriptions

Rank: 26 out of 300

555 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
45% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 555 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

32% of this provider’s 555 patients filled at least one prescription for a schedule three drug, compared to an average of 21%.

Risky Drugs to Seniors

3% of this provider’s 10,864 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 5%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $75 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
HYDROCODONE-ACETAMINOPHEN 1,145 660 S3 1 1
SIMVASTATIN 816 677 2 3
HYDROCHLOROTHIAZIDE 441 370 3 21
PRAVASTATIN SODIUM 428 372 4 17
LISINOPRIL 405 257 5 7
METFORMIN HCL 316 246 6 24
POTASSIUM CHLORIDE 315 266 7 20
METOPROLOL SUCCINATE 270 211 8 15
AMLODIPINE BESYLATE 269 225 9 4
OMEPRAZOLE 255 189 10 2
VERAPAMIL ER 241 213 11 152
METOPROLOL TARTRATE 239 219 12 26
LEVOTHYROXINE SODIUM 231 181 13 12
WARFARIN SODIUM 228 196 14 23
LISINOPRIL-HYDROCHLOROTHIAZIDE 195 177 15 47
CARISOPRODOL 187 70 R 16 28
LOVASTATIN 181 139 17 85
ZOLPIDEM TARTRATE 173 90 18 16
ATORVASTATIN CALCIUM 170 131 19 13
FUROSEMIDE 147 101 20 5
CLOPIDOGREL 145 119 21 18
RAMIPRIL 142 134 22 57
CRESTOR 134 113 23 49
NEXIUM 129 75 24 44
GABAPENTIN 128 66 25 6
NIASPAN 128 100 25 158
LOSARTAN POTASSIUM 123 103 27 29
AZITHROMYCIN 121 73 28 71
TAMSULOSIN HCL 121 117 28 9
CARVEDILOL 120 108 30 8
PANTOPRAZOLE SODIUM 118 81 31 45
ALENDRONATE SODIUM 117 106 32 79
GEMFIBROZIL 115 79 33 163
SPIRIVA 112 74 34 53
PLAVIX 112 91 34 32
CLONIDINE HCL 107 96 36 39
GLIMEPIRIDE 107 84 36 95
LOSARTAN-HYDROCHLOROTHIAZIDE 97 96 38 76
DIOVAN HCT 90 90 39 181
FLUOXETINE HCL 86 53 40 81
KLOR-CON 8 84 68 41 231
AMITRIPTYLINE HCL 82 59 R 42 43
SERTRALINE HCL 79 59 43 40
DONEPEZIL HCL 78 78 44 33
TRIAMTERENE-HCTZ 78 61 44 112
TRAZODONE HCL 77 45 46 51
GLIPIZIDE 76 59 47 156
FOSINOPRIL SODIUM 75 57 48 325
KLOR-CON 10 74 63 49 130
FENTANYL 73 60 S2 50 38
CITALOPRAM HBR 68 57 51 46
PAROXETINE HCL 67 46 52 103
TRAMADOL HCL 65 53 53 11
SINGULAIR 63 36 54 115
ADVAIR DISKUS 63 48 54 75
ESCITALOPRAM OXALATE 61 52 56 101
MELOXICAM 58 55 57 14
METOCLOPRAMIDE HCL 55 28 58 163
DIGOXIN 55 53 58 36
ENALAPRIL MALEATE 54 43 60 56
ZETIA 54 50 60 151
ATENOLOL 52 33 62 27
GLYBURIDE 51 44 R 63 141
INSULIN SYRINGE 51 43 63 155
HUMULIN 70-30 51 42 63 259
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 25, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.